Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATOM: Diclofenac Potassium vs Rimegepant for Acute Migraine
NCT05211154Phase 4Terminated
- Sponsor
- Dansk Hovedpinecenter
- Start
- May 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diclofenac in migraine, sponsored by Dansk Hovedpinecenter. Started May 2022; status: terminated.
02
Drugs
diclofenac
03
Conditions
migraine
Beyond the preview
Go deeper on NCT05211154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05211154.